JP2018538308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018538308A5 JP2018538308A5 JP2018532038A JP2018532038A JP2018538308A5 JP 2018538308 A5 JP2018538308 A5 JP 2018538308A5 JP 2018532038 A JP2018532038 A JP 2018532038A JP 2018532038 A JP2018532038 A JP 2018532038A JP 2018538308 A5 JP2018538308 A5 JP 2018538308A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- use according
- bladder
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 37
- 239000007788 liquid Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 206010005003 Bladder cancer Diseases 0.000 claims 4
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 4
- 238000009098 adjuvant therapy Methods 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 4
- 201000005112 urinary bladder cancer Diseases 0.000 claims 4
- -1 hexyl 5-ALA ester Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 238000009799 cystectomy Methods 0.000 claims 2
- 238000009099 neoadjuvant therapy Methods 0.000 claims 1
- 229960003301 nivolumab Drugs 0.000 claims 1
- 229960002621 pembrolizumab Drugs 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522311.8A GB201522311D0 (en) | 2015-12-17 | 2015-12-17 | Use |
| GB1522311.8 | 2015-12-17 | ||
| PCT/EP2016/081798 WO2017103280A1 (en) | 2015-12-17 | 2016-12-19 | Intravesical therapy for bladder cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018538308A JP2018538308A (ja) | 2018-12-27 |
| JP2018538308A5 true JP2018538308A5 (cg-RX-API-DMAC7.html) | 2020-02-06 |
Family
ID=55311161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532038A Pending JP2018538308A (ja) | 2015-12-17 | 2016-12-19 | 膀胱癌のための膀胱内療法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20180371101A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3390448B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2018538308A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102878726B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108699147B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016372570B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018012116A2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3390448T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2981986T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3390448T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201522311D0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3390448T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017103280A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016317915B2 (en) | 2015-09-01 | 2021-02-18 | Agenus Inc. | Anti-PD-1 antibodies and methods of use thereof |
| GB201522311D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
| EP3551225A1 (en) | 2016-12-07 | 2019-10-16 | Agenus Inc. | Antibodies and methods of use thereof |
| RU2760132C1 (ru) * | 2017-12-01 | 2021-11-22 | ЭсБиАй ФАРМАСЬЮТИКАЛЗ КО., ЛТД. | Фармацевтическая композиция для усиления противоопухолевого эффекта ингибитора иммунной контрольной точки |
| KR20250154511A (ko) | 2023-03-07 | 2025-10-28 | 포토큐어 에이에스에이 | 방광암 치료 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122006000051I2 (de) | 1995-03-10 | 2010-07-08 | Photocure Asa Hoffsveien 48 | Ester der 5-Aminolevulinsäure als Mittel zur Photosensibilisierung in der Chemotherapie |
| US7595048B2 (en) | 2002-07-03 | 2009-09-29 | Ono Pharmaceutical Co., Ltd. | Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| NZ600758A (en) | 2007-06-18 | 2013-09-27 | Merck Sharp & Dohme | Antibodies to human programmed death receptor pd-1 |
| EP2262837A4 (en) | 2008-03-12 | 2011-04-06 | Merck Sharp & Dohme | PD-1 BINDING PROTEINS |
| HUE030807T2 (en) * | 2008-09-26 | 2017-05-29 | Dana Farber Cancer Inst Inc | Human anti-PD-1, anti-PD-L1 and anti-PD-L2 antibodies and their applications |
| TWI605828B (zh) | 2008-12-09 | 2017-11-21 | 建南德克公司 | 抗ｐｄ-ｌ１抗體及其於增進ｔ細胞功能之用途 |
| JP6238459B2 (ja) | 2011-08-01 | 2017-11-29 | ジェネンテック， インコーポレイテッド | Ｐｄ−１軸結合アンタゴニストとｍｅｋ阻害剤を使用する癌の治療方法 |
| KR101764096B1 (ko) | 2011-11-28 | 2017-08-02 | 메르크 파텐트 게엠베하 | 항-ｐｄ-ｌ1 항체 및 그의 용도 |
| SG10201603055WA (en) | 2012-05-31 | 2016-05-30 | Genentech Inc | Methods Of Treating Cancer Using PD-L1 Axis Binding Antagonists And VEGF Antagonists |
| JP6954648B2 (ja) * | 2015-10-19 | 2021-10-27 | シージー オンコロジー， インコーポレイテッド | 併用療法による固形腫瘍又はリンパ系腫瘍の治療方法 |
| GB201522309D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
| GB201522311D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
-
2015
- 2015-12-17 GB GBGB1522311.8A patent/GB201522311D0/en not_active Ceased
-
2016
- 2016-12-19 CN CN201680079683.1A patent/CN108699147B/zh active Active
- 2016-12-19 EP EP16819062.7A patent/EP3390448B1/en active Active
- 2016-12-19 JP JP2018532038A patent/JP2018538308A/ja active Pending
- 2016-12-19 US US16/063,169 patent/US20180371101A1/en not_active Abandoned
- 2016-12-19 WO PCT/EP2016/081798 patent/WO2017103280A1/en not_active Ceased
- 2016-12-19 DK DK16819062.7T patent/DK3390448T3/da active
- 2016-12-19 KR KR1020187020008A patent/KR102878726B1/ko active Active
- 2016-12-19 AU AU2016372570A patent/AU2016372570B2/en active Active
- 2016-12-19 ES ES16819062T patent/ES2981986T3/es active Active
- 2016-12-19 BR BR112018012116-9A patent/BR112018012116A2/en active IP Right Grant
- 2016-12-19 FI FIEP16819062.7T patent/FI3390448T3/fi active
- 2016-12-19 PL PL16819062.7T patent/PL3390448T3/pl unknown
-
2019
- 2019-04-18 US US16/388,379 patent/US11066478B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018538308A5 (cg-RX-API-DMAC7.html) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
| EA201792541A3 (ru) | Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| EA201390840A1 (ru) | Полициклический lpaантагонист и его применение | |
| CR20190247A (es) | Métodos para el tratamiento de la atrofia muscular y enfermedad ósea con el uso de proteínas trap híbridas novedosas del ligando actriib | |
| EA201391263A1 (ru) | Комбинированные терапии гематологических опухолей | |
| ATE522225T1 (de) | Verwendung des peptids phpfhlfvy (renin- inhibitor) in anti-angiogenischer therapie von gewissen erkrankungen | |
| FI3484446T3 (fi) | Vasta-ainekoostumuksia | |
| AR094849A1 (es) | Terapia combinada que involucra anticuerpos dirigidos contra claudina 18.2 para el tratamiento de cáncer | |
| IL311873A (en) | Combination therapy for treating malignancies | |
| RU2018146886A (ru) | Пути терапевтического применения ингибитора c-raf | |
| EA201991704A3 (ru) | Моноклональные антитела против ингибитора пути тканевого фактора (tfpi) | |
| ATE553772T1 (de) | Verwendung von lvv-hämorphin-6 und optional af12198 als therapeutische(s) mittel | |
| EA201592287A1 (ru) | Замещенные тетрагидрокарбазольные и карбазолкарбоксамидные соединения | |
| SI2945620T1 (en) | Nitroxyl donors with improved therapeutic index | |
| FI3390448T3 (fi) | Intravesikaalinen hoito virtsarakon syöpää varten | |
| JP2020502198A5 (cg-RX-API-DMAC7.html) | ||
| FI3463436T3 (fi) | Rokote yhdistelmänä immuunivasteen tarkastuspisteen estäjän kanssa käytettäväksi hoidettaessa syöpää | |
| RU2014145841A (ru) | Терапевтический биопрепарат для лечения гепатоцеллюлярной карциномы | |
| JP2012522841A5 (cg-RX-API-DMAC7.html) | ||
| AU2020256847B2 (en) | Method of treating tumours | |
| JP2018537514A5 (cg-RX-API-DMAC7.html) | ||
| AR084216A1 (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit |